We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17.7B
AUM Growth
+$1.64B
Cap. Flow
+$829M
Cap. Flow %
4.68%
Top 10 Hldgs %
32.88%
Holding
1,375
New
60
Increased
737
Reduced
285
Closed
62

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$115M
2
ESS icon
Essex Property Trust
ESS
+$110M
3
AAPL icon
Apple
AAPL
+$103M
4
TSLA icon
Tesla
TSLA
+$101M
5
MSFT icon
Microsoft
MSFT
+$97.5M

Top Sells

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$122M
2
SUI icon
Sun Communities
SUI
+$107M
3
SPG icon
Simon Property Group
SPG
+$104M
4
WPC icon
W.P. Carey
WPC
+$76.5M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$70.5M

Sector Composition

Rank Sector Weight
1 Real Estate 45.88%
2 Technology 16.72%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
1176
Twist Bioscience
TWST
$5.38B
$7K ﹤0.01%
210
– –
AGIO icon
1177
Agios Pharmaceuticals
AGIO
$2.09B
$6K ﹤0.01%
204
– –
ARDX icon
1178
Ardelyx
ARDX
$1.24B
$6K ﹤0.01%
754
– –
AVDL
1179
DELISTED
Avadel Pharmaceuticals
AVDL
$6K ﹤0.01%
332
+87
+36% +$1.3K
EWTX icon
1180
Edgewise Therapeutics
EWTX
$4.28B
$6K ﹤0.01%
344
+90
+35% +$1.43K
IRON icon
1181
Disc Medicine
IRON
$2.82B
$6K ﹤0.01%
99
– –
PTGX icon
1182
Protagonist Therapeutics
PTGX
$8.6B
$6K ﹤0.01%
215
+52
+32% +$1.42K
VCYT icon
1183
Veracyte
VCYT
$4.46B
$6K ﹤0.01%
266
– –
FUSN
1184
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$6K ﹤0.01%
+268
New +$3.21K
INBX
1185
DELISTED
Inhibrx, Inc. Common Stock
INBX
$6K ﹤0.01%
175
– –
ABCL icon
1186
AbCellera Biologics
ABCL
$1.66B
$5K ﹤0.01%
1,151
– –
ADMA icon
1187
ADMA Biologics
ADMA
$2.02B
$5K ﹤0.01%
791
– –
AKRO
1188
DELISTED
Akero Therapeutics
AKRO
$5K ﹤0.01%
188
– –
ANIP icon
1189
ANI Pharmaceuticals
ANIP
$1.86B
$5K ﹤0.01%
70
– –
COLL icon
1190
Collegium Pharmaceutical
COLL
$1.17B
$5K ﹤0.01%
127
– –
DAWN
1191
DELISTED
Day One Biopharmaceuticals
DAWN
$5K ﹤0.01%
296
– –
DBC icon
1192
Invesco DB Commodity Index Tracking Fund
DBC
$1.7B
$5K ﹤0.01%
200
– –
GERN icon
1193
Geron
GERN
$917M
$5K ﹤0.01%
1,407
– –
GMAB icon
1194
Genmab
GMAB
$17.5B
$5K ﹤0.01%
172
– –
KURA icon
1195
Kura Oncology
KURA
$814M
$5K ﹤0.01%
227
– –
LGND icon
1196
Ligand Pharmaceuticals
LGND
$5.82B
$5K ﹤0.01%
63
– –
MNKD icon
1197
MannKind Corp
MNKD
$1.2B
$5K ﹤0.01%
1,058
– –
PCRX icon
1198
Pacira BioSciences
PCRX
$1.04B
$5K ﹤0.01%
169
– –
PRTA icon
1199
Prothena Corp
PRTA
$454M
$5K ﹤0.01%
195
– –
VIR icon
1200
Vir Biotechnology
VIR
$1.47B
$5K ﹤0.01%
535
– –
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2024 Portfolio in Review

As of Q1 2024, Daiwa Securities Group held 1,375 positions worth $17.7B, up 10% from $16.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group deployed $829M of net new capital in Q1 2024, opening 60 new positions and adding to 737 existing holdings. Its largest new stake was American Healthcare REIT: 241,461 shares worth $3.56M.

By sector, the portfolio is most concentrated in Real Estate at 46% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $122M trimmed.

  • Daiwa Securities Group's largest Q1 2024 buy was American Healthcare REIT: 241,461 shares worth $3.56M.
  • Daiwa Securities Group added most to Equinix in Q1 2024, an estimated $115M increase.
  • Daiwa Securities Group's biggest Q1 2024 reduction was Mid-America Apartment Communities, cutting an estimated $122M.
  • Daiwa Securities Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $70.5M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $17.7B portfolio in Q1 2024.
  • Daiwa Securities Group opened 60 new positions and closed 62 in Q1 2024.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $17.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.